PIK3CA amplifications as well as PTEN mutations were reported for many FTCs, PTCs and ATCs suggesting that AKT signaling is sustained by genomic alterations and modified by post-transcriptional control in thyroid carcinomas [17,58,59]. This evidence concerns the gene AKT1 and Ehlers-Danlos syndrome, musculocontractural type.